Partnership to End Addiction supports reducing barriers to effective substance use disorder treatment, including eliminating the DATA 2000 waiver required to prescribe buprenorphine.
We have compiled a comprehensive set of effective policies and practices that identifies specific actions for improving the prevention and treatment of risky substance use and addiction in the U.S.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.